HIF-1α is a prognostic marker in oral squamous cell carcinomas

International Journal of Biological Markers

Volumn 25, Issue 2, 2010, Pages 87-92

  Eckert, Alexander W ^a   Schütze, Andreas ^a   Lautner, Matthias H W ^a   Taubert, Helge ^a   Schubert, Johannes ^a   Bilkenroth, Udo ^b  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b Institute of Pathology   (Germany)

Author keywords

Head and neck cancer; HIF 1 ; Multivariate analysis; Oral cancer; OSCC; Prognosis

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; HIF1A PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; ALVEOLAR RIDGE; ARTICLE; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; CHEEK MUCOSA; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; DISEASE MARKER; FEMALE; HARD PALATE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPEROXIDASE STAINING; MAJOR CLINICAL STUDY; MALE; MOUTH; MOUTH CARCINOMA; ORAL SQUAMOUS CELL CARCINOMA; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; REGRESSION ANALYSIS; SOFT PALATE; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TONGUE; EVALUATION; METABOLISM; MIDDLE AGED; MORTALITY; MOUTH TUMOR; PATHOLOGY; PHYSIOLOGY; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 77954941837     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.1177/172460081002500205     Document Type: Article

References (23)

1. Harris AL. Hypoxia - a key regulatory factor in tumor growth. Nature Rev Cancer 2002; 2: 38-47. (Pubitemid 37328806)
2. Janssen HL, Haustermanns KM, Balm AJ, Begg AC. Hypoxia in head and neck cancer: how much, how important? Head Neck 2005; 27: 622-38.
3. Vaupel P, Mayer A. Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastas Rev 2007; 26: 225-39. (Pubitemid 47101660)
4. Semenza GL. Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene 2010; 29: 625-34.
5. Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003; 3: 721-32.
6. Calzada MJ, del Peso L. Hypoxia-inducible factors in cancer. Clin Transl Oncol 2007; 5: 278-89.
7. Rankin EB, Giaccia AJ. The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ 2008; 15: 678-85.
8. Semenza GL. Hypoxia-inducible factor 1 and cancer pathogenesis. IUBMB Life 2008; 60: 591-7.
9. Beasley NJP, Leek R, Alam M, et al. Hypoxia-inducible factors HIF-1α and HIF-2α in head and neck cancer: relationship to tumor biology and treatment outcome in surgically resected patients. Cancer Res 2002; 62: 2493-7.
10. Fillies T, Werkmeister R, van Diest PJ, Brandt B, Joos U, Burger H. HIF1-alpha overexpression indicates a good prognosis in early stage squamous cell carcinomas of the oral floor. BMC Cancer 2005; 5: 84.
11. Koukourakis MI, Bentzen SM, Giatromanolaki A, et al. Endogenous markers of two separate hypoxia response pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) are associated with radiotherapy failure in head and neck cancer patients recruited in the CHART randomized trial. J Clin Oncol 2006; 24: 727-35.
12. Winter SC, Shah KA, Han C, et al. The relation between hypoxia-inducible factor (HIF)-1 alpha and HIF-2 alpha expression with anemia and outcome in surgically treated head and neck cancer. Cancer 2006; 107: 757-66. (Pubitemid 44232668)
13. Lin P-Y, Yu C-H, Wang J-T, et al. Expression of hypoxia-inducible factor 1α is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan. J Oral Pathol Med 2008; 37: 18-25. (Pubitemid 350264782)
14. Kunkel M, Morgel M, Stockinger M, et al. Overexpression of GLUT-1 is associated with resistance to radiotherapy and adverse prognosis in squamous cell carcinoma of the oral cavity. Oral Oncol 2007; 43: 796-803. (Pubitemid 47263526)
15. Yoshiba S, Ito D, Nagumo T, Shirota T, Hatori M, Shintani S. Hypoxia induces resistance to 5-fluorouracil in oral cancer cells via G(1) phase cell cycle arrest. Oral Oncol 2009; 45: 109-15.
16. Eckert AW, Lautner MHW, Taubert H, Schubert J, Bilkenroth U. Expression of Glut-1 is a prognostic marker for oral squamous cell carcinoma patients. Oncol Rep 2008; 20: 1381-5.
17. Dellas K, Bache M, Pigorsch SU, et al. Prognostic impact of HIF-1α expression in patients with definitive radiotherapy for cervical cancer. Strahlenther Onkol 2008; 184: 169-74. (Pubitemid 351365780)
18. Remmele W, Stegner HE. Recommendation for uniform detection of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe 1987; 8: 138-40.
19. Denko NC. Hypoxia, HIF 1 and glucose metabolism in the solid tumor. Nature Rev Cancer 2008; 8: 705-13.
20. Uehara M, Sano K, Ikeda H, Nonaka M, Asahina I. Hypoxia-inducible factor 1 alpha in oral squamous cell carcinoma and its relation to prognosis. Oral Oncol 2009; 45: 241-6.
21. Roh JI, Cho KJ, Kwon GY, et al. The prognostic value of hypoxia markers in T2-staged oral tongue cancer. Oral Oncol 2009; 45: 63-8.
22. Liu SY, Chang LC, Pan LF, Hung CH, Shieh YS. Clinicopathologic significance of tumor cell-lined vessel and microenvironment in oral squamous cell carcinoma. Oral Oncol 2008; 44: 277-85.
23. Aebershold DM, Burri P, Beer KT, et al. Expression of hypoxia-inducible factor 1 alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. Cancer Res 2001; 61: 2911-6. (Pubitemid 32691934)